Abcam extends capabilities with the acquisition of Marker Gene Technologies
LONDON: Abcam Plc, a global innovator in life science reagents and tools, announced the acquisition of the entire issued share capital of Marker Gene Technologies (MGT). Financial terms of the acquisition have not been disclosed and are expected to have…